A Pilot Randomized Controlled Trial of a Social Network Intervention
Part of paid clinical trials in Rochester, New York.
- Sponsor
- University of Rochester
- Study ID
- NCT07393529
- Status
- Recruiting
Conditions
- Advanced Cancer
- Older Adults (65 Years and Older)
- Social Networks
Eligibility Criteria
- Sex
- ALL
- Age
- 65 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- SONATA — BEHAVIORALSONATA includes six evidence-based components to help patients: 1) identify and set personal goals to achieve well-being (goal-setting); 2) identify their social network (SN) members and map their SNs (network diagnostics); 3) engage key SN members to address their goals and needs (network engagement); 4) build channels for communication and collaboration with key SN members via in-person and virtual activities (opportunity creation); 5) communicate effectively with their key SN members, develop action plans, and provide support (skill building); and 6) engage in cycles of feedback to effectively respond to the patient's evolving needs.
Study Details
This is a pilot randomized controlled trial to assess the feasibility, acceptability, appropriateness, and structure of the SONATA intervention. In addition, it will assess the preliminary efficacy of SONATA compared to enhanced usual care among 70 older adults with advanced cancer.
Key Dates
- Start date
- Apr 10, 2026
- Status verified
- Apr 2026
- Primary completion
- Mar 31, 2029
- Completion
- Mar 31, 2029
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: SONATA InterventionFollowing randomization, patients assigned to SONATA will participate in up to six coaching sessions, delivered either in person or via Zoom over approximately six weeks.
- No Intervention: Enhanced Usual CarePatients randomized to enhanced usual care will receive standard educational materials within 4 weeks of randomization.
Primary Outcome Measure
Study feasibility [ Time Frame: From baseline to week 16 ]
Central Contacts
- Kah Poh Loh585-276-4353
- Becky Gravenstede585-727-4728
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Rochester | Rochester | New York | 14642 | - |
Find similar trials in Rochester, NY
By research site
Related Studies
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · Artios Pharma Ltd · Birmingham, Alabama
- Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsPHASE1 · Recruiting · I-Mab Biopharma US Limited · Orange, California
- A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor CancerPHASE1/PHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · New York, New York
- Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid TumorsPHASE1 · Recruiting · Riboscience, LLC. · Scottsdale, Arizona